Market Research Future.com add new report of “Clinical Perinatal Software Market Research Report – Global Forecast To 2023” it contains Company information, geographical data and Table of Content Clinical Perinatal Software Market information: by products (integrated software and standalone software), by services (implementation services and others), by deployment models (on-premises and cloud-based), by applications (Fetal monitor data services and others), and end user - Forecast till 2023 the clinical perinatal software monitor health of fetus and pregnant women. It provides information about any complexity that may arise during the prenatal period, which helps to minimize the problems during the pregnancy. The Global Clinical Perinatal Software Market is growing at a steady pace and is expected to grow at a CAGR of ~7.2 % during review period 2017-2023. Increasing awareness and a rising birth rate & post-date pregnancy drive the growth of the market. Moreover, increasing healthcare expenditure, continuous development in technology, and increasing government support for research & development likely to boost the demand for the software. On the other hand, complex user interface and high cost of the software may slow the market growth over the assessment period. Some of the key players in this market: General Electric, Edan Instruments, Inc., Huntleigh Healthcare Limited, KONINKLIJKE PHILIPS N.V, K2 Medical Systems, PeriGen, Inc, Cerner Corporation, Trium Analysis Online, and others. Request a Sample Report @ https://www.marketresearchfuture.com/sample_request/4185. Clinical Perinatal Software Market has been segmented on the basis of products, which comprises of integrated software and standalone software. On the basic of services, the market is segmented into implementation services, support & maintenance services, training service, customization services, and online resources. On the basic of deployed models, the market is segmented on-premises and cloud- based. On the basis of applications, the market is segmented into fetal monitor data services, workflow management, and patient documentation. On the basis of end users, it is segmented into hospital & clinics and maternity clinics. Regional Analysis of the Global Clinical Perinatal Software Market The Americas region accounted for a lion share of USD 65.31 million in 2016, owing to the well-developed technology, high healthcare expenditure, and the presence of the leading players. Europe is the second largest market that holds a noticeable share of the Global Clinical Perinatal Software Market. The European market is expected to grow significantly during the forecast period owing to well-developed healthcare infrastructure and increasing investment in healthcare. Germany, the UK, and France contribute significantly to the growth of the European market. In Asia Pacific, rising number of hospitals, increasing need for better diagnostic methods, and demand for cost-effective treatment & diagnostics services are the key factors for the market growth. The Middle East & Africa is expected to show steady growth in this market due to low technology penetration and less availability of innovative healthcare technologies. Key Findings The Global Clinical Perinatal Software Market and is expected to reach USD 60 million by 2023. Integrated software segment on the basis of products holds the largest share of 75.8% of the market.